you are here: HomeNewsIndia

No COVID-19 vaccination drive on January 26-27, states to review stockpile: Report

This break will be used by state authorities to check the COVID-19 vaccine stockpile and review their database.

January 23, 2021 / 08:31 AM IST
Representative image: AP

Representative image: AP

States are likely to take a break from the nationwide COVID-19 vaccination drive on January 26-27, based on instruction from the Union Health Ministry, The Economic Times reported.

According to the news report, the health ministry has asked states to not plan any vaccination sessions on Republic Day. The break may be extended by a day in some bigger states.

This break will be used by state authorities to check the COVID-19 vaccine stockpile and review their database. They will check how many beneficiaries missed getting the first dose.

A senior health ministry official, who asked not to be identified, told the newspaper that this break would be used to strategise how to cover the remaining beneficiaries over the next two weeks. “The states would plan their sessions, increase session sites and gauge their stockpile of vaccines in this time,” the official added.

Follow our LIVE blog for the latest updates of the coronavirus pandemic


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The second batch of Serum Institute of India (SII)’s Covishield and Bharat Biotech’s Covaxin vaccines will also reportedly reach some states during these two days.

Around 10.4 lakh beneficiaries have been given at least the first dose of the COVID-19 vaccine since the drive started on January 16.

Priority is being given to healthcare and frontline workers, who had already been registered on the purpose-built CoWIN application. This would be sequentially followed by people with comorbidities, senior citizens and finally, the general public. The Centre is hoping to vaccinate 30 crore people by July, in a bid to stop the novel coronavirus pandemic.

COVID-19 Vaccine Tracker: All you need to know about manufacturing and pricing

As of January 22, India had reported more than 1.06 crore confirmed COVID-19 cases. The death toll from the outbreak in the country stood at over 1.53 lakh. While more than 1.02 crore patients had recovered, 1.88 lakh cases remained ‘active’. Globally, more than 9.76 crore individuals have been infected by the virus and over 20.97 lakh people have died so far.

A speedy rollout of vaccines is being seen as the best way to curb the spread of COVID-19 and restore normalcy in the pandemic-battered global economy. Several countries have already vaccinated a significant number of people from high-risk groups.

Click here for Moneycontrol’s full coverage of the coronavirus pandemic
Moneycontrol News
first published: Jan 23, 2021 08:31 am

stay updated

Get Daily News on your Browser